Global investment company KKR is set to buy Eugin, the Spain-based fertility subsidiary owned by Germany-based conglomerate Fresenius, for €500m. We ask why KKR might want it, and whether it makes sense for Fresenius to sell.
With UK for-profit group Cygnet Health Care being fined £1.5m last month following the death of an inpatient at Ealing Hospital in 2019 - the largest ever penalty imposed on a mental health provider - we speak to four European experts to consider how punitive fines from regulators are impacting providers’ bottom line.
The Hungarian hospital market is growing at 10% per year nominally, with some of the biggest players outstripping this. With such rapid growth and growing demand the potential reward for investors is great – but with this also comes big risks.
Italy has historically been less affected by the health care workforce crisis gripping much of Europe, but HBI hears post-Covid pressure has created a nursing crisis which has seen wages shoot up, and led prime minister Giorgia Meloni to look abroad. Most recently she has signed an agreement with the Caribbean island of Cuba to fix her growing workforce challenge. This is the latest in a series of deals and rule relaxations designed to help funnel talent into Western Europe.
Last week, Amanat Holdings announced the return of Howard Podolsky to Cambridge Medical Rehabilitation Center. HBI caught up with the ‘new’ group CEO to hear about current challenges and opportunities in the Middle East and what is different this time around.
Last week, HBI joined thousands of delegates at the Health Excellence Through Technology (HETT) 2023 conference in London, where exhibiters congregated to explore how digital innovation can be leveraged to address record-level NHS waiting lists - something keynote speaker Vin Diwakar, medical director for transformation dubbed “the greatest crisis since the Second World War.”
Just in time for Halloween, Robert Fico is back. The former Slovakian prime minister who tried to renationalise insurer Dôvera has led his populist centre-left party to win the most seats in Slovakia’s 2023 elections. But a Slovak operator source tells HBI the private sector need not worry as even if Fico forms a government, it is unlikely to be the horror show some fear.
HBI speaks to an oncology operator in Portugal who tells us that whilst there is no risk of public referrals running dry any time soon, the sector is being held back by stingy tariffs for publicly-funded care and a licensing system that favours the public sector.
US-based global investment company KKR looks set to buy Eugin, the Spain-based fertility group owned by Germany-based conglomerate Fresenius, with which it is reportedly in exclusive talks. The deal values Eugin at around €500m.
HBI hears that a glut of M&A deals are being rushed through, with panicking investors and operators competing for buyers before Federal Health Minister Karl Lauterbach's controversial reforms pass - though it remains unclear exactly what those reforms will be. HBI asks whether the panic is merited, just how low have multiples dropped, and who will benefit from this?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.